Total Payments
$6,138
2024 Payments
$533.56
Companies
32
Transactions
440
Medicare Patients
1,035
Medicare Billing
$89,543
Payment Breakdown by Category
Food & Beverage$6,117 (99.7%)
Education$20.52 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,117 | 438 | 99.7% |
| Education | $20.52 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,517 | 167 | $0 (2022) |
| Amgen Inc. | $773.00 | 43 | $0 (2024) |
| ABBVIE INC. | $588.71 | 68 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $500.31 | 23 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $430.25 | 10 | $0 (2023) |
| Amarin Pharma Inc. | $369.67 | 9 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $254.60 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $196.08 | 12 | $0 (2024) |
| Novo Nordisk Inc | $193.56 | 13 | $0 (2024) |
| PFIZER INC. | $177.31 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $533.56 | 55 | Amgen Inc. ($139.48) |
| 2023 | $562.60 | 38 | AbbVie Inc. ($223.77) |
| 2022 | $1,349 | 104 | Janssen Pharmaceuticals, Inc ($415.98) |
| 2021 | $390.23 | 28 | Sunovion Pharmaceuticals Inc. ($249.54) |
| 2020 | $210.56 | 21 | Sunovion Pharmaceuticals Inc. ($126.32) |
| 2019 | $1,028 | 58 | Sunovion Pharmaceuticals Inc. ($437.16) |
| 2018 | $968.26 | 64 | Sunovion Pharmaceuticals Inc. ($221.22) |
| 2017 | $1,095 | 72 | Sunovion Pharmaceuticals Inc. ($316.92) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 11/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Oncology | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $28.52 | General |
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/31/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 291 | 405 | $54,105 | $24,272 |
| 2022 | 5 | 281 | 433 | $54,460 | $26,720 |
| 2021 | 5 | 219 | 352 | $40,584 | $21,550 |
| 2020 | 4 | 244 | 401 | $36,645 | $17,001 |
Total Patients
1,035
Total Services
1,591
Medicare Billing
$89,543
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $16,050 | $7,963 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 120 | $15,408 | $7,045 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 123 | $10,897 | $4,799 | 44.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 46 | $4,178 | $1,791 | 42.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $2,443 | $1,428 | 58.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 26 | $4,557 | $988.69 | 21.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $572.00 | $257.19 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 165 | $21,108 | $11,017 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 186 | $16,338 | $7,804 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $10,531 | $5,578 | 53.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 26 | $4,456 | $1,191 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $2,027 | $1,130 | 55.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 157 | $18,678 | $11,033 | 59.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 128 | $10,398 | $5,528 | 53.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 30 | 30 | $6,946 | $3,901 | 56.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 17 | 23 | $2,285 | $545.87 | 23.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 14 | $2,277 | $541.20 | 23.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 99 | 212 | $15,995 | $7,237 | 45.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 118 | $13,540 | $6,353 | 46.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 27 | 27 | $6,037 | $3,073 | 50.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 42 | 44 | $1,074 | $337.85 | 31.5% |
About Dr. David Dotson, MD
Dr. David Dotson, MD is a Family Medicine healthcare provider based in Owosso, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437148798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dotson, MD has received a total of $6,138 in payments from pharmaceutical and medical device companies, with $533.56 received in 2024. These payments were reported across 440 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,117).
As a Medicare-enrolled provider, Dotson has provided services to 1,035 Medicare beneficiaries, totaling 1,591 services with total Medicare billing of $89,543. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Owosso, MI
- Active Since 10/19/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437148798
Products in Payments
- LATUDA (Drug) $1,509
- Livalo (Drug) $483.35
- XARELTO (Drug) $430.25
- VRAYLAR (Drug) $389.43
- Vascepa (Drug) $369.67
- Aimovig (Biological) $293.12
- XIFAXAN (Drug) $254.60
- Otezla (Drug) $212.29
- Prolia (Biological) $159.59
- EMGALITY (Drug) $140.99
- ENTRESTO (Drug) $124.11
- CHANTIX (Drug) $112.96
- Rybelsus (Drug) $91.56
- Cologuard Collection Kit (Device) $80.41
- NURTEC ODT (Drug) $73.10
- Humira (Biological) $72.00
- TRELEGY ELLIPTA (Drug) $69.83
- AREXVY (Drug) $56.10
- CAPLYTA (Drug) $53.37
- TEPEZZA (Biological) $49.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Owosso
Anthony Patsy, Do, DO
Family Medicine — Payments: $58,360
Family Medicine $58,360
Dr. John Behm, D.o, D.O
Family Medicine — Payments: $7,616
Family Medicine $7,616
Timothy Oliver, Md, MD
Family Medicine — Payments: $6,111
Family Medicine $6,111
Carol Vorenkamp-Cooper, Do, DO
Family Medicine — Payments: $4,727
Family Medicine $4,727
Jimmy Qaqish, Md, MD
Family Medicine — Payments: $3,173
Family Medicine $3,173
Phincy Arangattu, Md, MD
Family Medicine — Payments: $2,779
Family Medicine $2,779